Alkali Metals Limited (ALKALI.BO)
- Previous Close
85.66 - Open
85.79 - Bid 83.60 x --
- Ask 87.80 x --
- Day's Range
83.60 - 86.18 - 52 Week Range
75.26 - 165.00 - Volume
2,680 - Avg. Volume
3,203 - Market Cap (intraday)
853.294M - Beta (5Y Monthly) 0.52
- PE Ratio (TTM)
-- - EPS (TTM)
-8.90 - Earnings Date May 23, 2025 - May 27, 2025
- Forward Dividend & Yield 1.00 (1.19%)
- Ex-Dividend Date Aug 16, 2024
- 1y Target Est
--
Alkali Metals Limited manufactures and sells chemicals in India and internationally. The company offers API products, including benzocaine, fluconazole, loperamide hydrochloride, losartan potassium, metformin hydrochloride, phenylephrine hydrochloride, and rabeprazole sodium. It also provides pyridine, acetylpyridine, alkyl borate, aminopyridine, bipyridine, bromopyridine, chloropyridine, cyanopyridine, cyclic, diethylamino pyridine, ethoxypyridine, fluoropyridine, hydroxypyridine, methoxypyridine, nitropyridine, picolylalcohol, pyridine n-oxide, pyrimidine, tetrazole, and triazole compounds; azaindole, potassium, sodium, and other metal derivatives; and boronic acids, fine chemicals, and DSSC and OLED materials. The company's products are used in pharma intermediates, anti retrovirals, flu vaccines, antibiotics, cardio/anti inflammation, agrochemicals, and automobiles applications. Alkali Metals Limited was incorporated in 1968 and is based in Hyderabad, India.
www.alkalimetals.com107
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: ALKALI.BO
View MorePerformance Overview: ALKALI.BO
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALKALI.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALKALI.BO
View MoreValuation Measures
Market Cap
853.29M
Enterprise Value
1.07B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.05
Price/Book (mrq)
1.90
Enterprise Value/Revenue
1.32
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-11.72%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
818.8M
Net Income Avi to Common (ttm)
-95.99M
Diluted EPS (ttm)
-8.90
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--